Atlas Trials

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Clinical trial NCT00133731 · COMPLETED

Trial details

NCT number
NCT00133731
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Angioplasty, Transluminal, Percutaneous Coronary
Start date
2004-09-01
Enrollment
947

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.